Critics of a major drug price overhaul hope a fresh federal cabinet will put a temporary stop to the new regulations set to take effect in January. The Patented Medicine Prices Review Board is set to change the way it sets a price cap on medicines in Canada in an effort to lower excessively expensive drug costs. […]
For the third time in a row, the federal government is delaying long-awaited changes to Canada’s drug pricing regime for a further six months. In an effort to give pharmaceutical companies more time to prepare for the impending changes, Health Minister Patty Hajdu announced Tuesday the regulations changing how the Patented Medicine Prices Review Board […]
The Financial Services Regulatory Authority of Ontario is establishing a technical advisory committee to provide insights on the province’s existing regulatory processes for employer-based pension plans. The committee’s 10 to 14 members will examine current regulatory processes in order to improve pension plan administration through cost-efficient and innovative practices. They’ll also discuss approaches to help ensure Ontario’s pension plan […]
Despite concerns Canadian drug prices are skyrocketing, the Patented Medicines Price Review Board, Canada’s price regulator, has ensured costs for patented drugs haven’t increased more than the Canadian Consumer Price Index in close to 30 years, said Wayne Critchley, Global Public Affairs’ senior associate of health and life sciences, during Benefits Canada’s Face to Face […]
The Office of the Superintendent of Financial Institutions is launching a three-month consultation on risks arising from climate change that can affect the safety and soundness of federally-regulated pension plans and financial institutions. Along with a discussion paper, the consultation’s objective is to understand how plans and institutions identify, measure and build resilience to climate […]
U.S. stock futures and markets around the world are mostly holding steady or ticking higher in early Wednesday trading, but only after spinning through an election night dominated by surprises and sharp swings. After rallying early this week amid hopes that Election Day’s arrival could clear the uncertainty that’s been weighing on markets, Treasury yields […]
The Office of the Superintendent of Financial Institutions is launching a three-month consultation on risks and other considerations regarding technological advancements impacting Canada’s financial sector. Along with a discussion paper, the consultation’s objective is to ensure federally regulated financial institutions and pension plans have solid strategies to manage non-financial risks. According to the agency, while rapidly […]
The Financial Services Regulatory Authority is seeking stakeholder input on draft guidance on providing consent for asset transfer transactions under the Pension Benefits Act. Aiming to support predictability and transparency for defined benefit plan administrators, sponsors and members and to protect of the rights of members, the guidance sets out how the FSRA will exercise its discretion and […]
The Office of the Superintendent of Financial Institutions is lifting the temporary freeze on portability transfers for private pension plans. The move reverses the OSFI’s response in March to market volatility caused by the coronavirus pandemic, which froze portability transfers and annuity purchases from defined benefit pension plans. The restrictions are no longer needed, it noted in a […]
Canada’s pension regulations have been designed to govern defined benefit plans and are a bad fit for target-benefit and multi-employer pension plans, according to a new report by the C.D. Howe Institute. The report, authored by Barry Gros, a retired actuary and chair of the University of British Columbia staff pension plan, argued that the […]